facilities , while Novo Nordisk has invested $11 billion to acquire and upgrade Catalent manufacturing sites
It's not a generic probiotic but a formula with a specific metabolic focus
The large DEVOTE trial confirmed its heart safety in high-risk adults and showed a 40% drop in severe low blood sugar and 53% fewer nighttime episodes compared to insulin glargine
These effects are believed to stem from changes in reward and impulse-control pathways in the brain
Its future role, safety, and indications depend on complete trial data and regulatory review
Headache or dizziness: This can be caused by the medication itself, or by the medication making you less likely to drink water or consume enough calories, either of which can lead to feeling light-headed, dizzy, or headachey